Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu(®)): An open label, uncontrolled study

von Vinnemeier, Christof David, Fischer-Herr, Johanna, Meyer, Seetha, Liebig, Katja, Theeß, Wiebke, Burchard, Gerd-Dieter, Cramer, Jakob P
Veröffentlicht 2014

Clinical Trial to Evaluate the Safety and Immunogenicity of a Trivalent Surface Antigen Seasonal Influenza Vaccine Produced in Mammalian Cell Culture and Administered to Young and...

von Loebermann, Micha, Voss, Ulrich, Meyer, Seetha, Bosse, Dietrich, Fritzsche, Carlos, Klammt, Sebastian, Frimmel, Silvius, Riebold, Diana, Reisinger, Emil C.
Veröffentlicht 2013

A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study

von Roggelin, Louise, Vinnemeier, Christof D, Meyer, Seetha, Witte, Kai, Marx, Lydia, Theeß, Wiebke, Burchard, Gerd D, Rolling, Thierry, Cramer, Jakob P
Veröffentlicht in Hum Vaccin Immunother (2015)